Display options
Cite
Chamali B, Finnamore H, Manning R, et al. Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia - an observational study. Intractable Rare Dis Res. 2016;5(2):109-13doi: 10.5582/irdr.2016.01019.
Chamali, B., Finnamore, H., Manning, R., Laffan, M. A., Hickson, M., Whelan, K., & Shovlin, C. L. (2016). Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia - an observational study. Intractable & rare diseases research, 5(2), 109-13. https://doi.org/10.5582/irdr.2016.01019
Chamali, Basel, et al. "Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia - an observational study." Intractable & rare diseases research vol. 5,2 (2016): 109-13. doi: https://doi.org/10.5582/irdr.2016.01019
Chamali B, Finnamore H, Manning R, Laffan MA, Hickson M, Whelan K, Shovlin CL. Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia - an observational study. Intractable Rare Dis Res. 2016 May;5(2):109-13. doi: 10.5582/irdr.2016.01019. PMID: 27195194; PMCID: PMC4869576.
Copy Download .nbib Format: NLM
Share it on

Intractable Rare Dis Res. 2016 May;5(2):109-13. doi: 10.5582/irdr.2016.01019.

Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia - an observational study.

Intractable & rare diseases research

Basel Chamali, Helen Finnamore, Richard Manning, Michael A Laffan, Mary Hickson, Kevin Whelan, Claire L Shovlin

Affiliations

  1. National Heart and Lung Institute Cardiovascular Sciences, Imperial College London, UK; Imperial College School of Medicine, Imperial College London, UK.
  2. National Heart and Lung Institute Cardiovascular Sciences, Imperial College London, UK; Diabetes and Nutritional Sciences Division, King's College London, UK.
  3. Haematology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  4. Haematology Department, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK; Centre for Haematology, Imperial College London, UK.
  5. Nutrition and Dietetics, Imperial College Healthcare NHS Trust, London, UK (Current address: School of Health Professions, Plymouth University, Plymouth, UK).
  6. Diabetes and Nutritional Sciences Division, King's College London, UK.
  7. National Heart and Lung Institute Cardiovascular Sciences, Imperial College London, UK; HHTIC London, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.

PMID: 27195194 PMCID: PMC4869576 DOI: 10.5582/irdr.2016.01019

Abstract

Understanding potential provocations of haemorrhage is important in a range of clinical settings, and particularly for people with abnormal vasculature. Patients with hereditary haemorrhagic telangiectasia (HHT) can report haemorrhage from nasal telangiectasia in real time, and suggested dietary factors may precipitate nosebleeds. To examine further, nosebleed severity, dietary supplement use, and blood indices were evaluated in an unselected group of 50 HHT patients recruited from a specialist UK service. Using the validated Epistaxis Severity Score, nosebleed severity ranged from 0 to 9.1 out of 10 (median 3.9). Using a Food Frequency Questionnaire, 24/50 (48%) participants reported use of dietary supplements in the previous year. A third (18/50; 36%) had used self prescribed, non-iron containing dietary supplements, ingesting between 1 and 3 different supplements each day. Eight (16%) used fish oils. Despite having more severe epistaxis (p = 0.012), the 12 iron supplement users had higher serum iron concentrations, and were able to maintain their red blood cell indices. In contrast, there was no evident benefit for the participants using non iron supplements. Furthermore, platelet counts and serum fibrinogen tended to be lower in fish oil/supplement users, and one fish oil user demonstrated reduced in vitro platelet aggregation. In conclusion, in this small study, a third of HHT patients used non-iron dietary supplements, and one in six ingested fish oils, unaware of their known anti-platelet activity. The scale of use, and potential of these "natural health supplements" to exacerbate nosebleeds has not been appreciated previously in HHT.

Keywords: Diet; Epistaxis; Iron; epistaxis severity score (ESS); fish oils

References

  1. Am J Med Genet. 2000 Mar 6;91(1):66-7 - PubMed
  2. Rhinology. 2005 Mar;43(1):40-6 - PubMed
  3. FASEB J. 2006 Feb;20(2):353-5 - PubMed
  4. Rep Health Soc Subj (Lond). 1991;41:1-210 - PubMed
  5. Laryngoscope. 2010 Apr;120(4):838-43 - PubMed
  6. Blood Rev. 2010 Nov;24(6):203-19 - PubMed
  7. Thromb Res. 2011 Oct;128(4):335-40 - PubMed
  8. Rhinology. 2011 Jun;49(2):155-62 - PubMed
  9. Rhinology. 2011 Jun;49(2):164-7 - PubMed
  10. Thromb Haemost. 2011 Sep;106(3):457-65 - PubMed
  11. Nutr Rev. 2012 Feb;70(2):107-17 - PubMed
  12. Am J Med Genet A. 2012 Jun;158A(6):1269-78 - PubMed
  13. Laryngoscope. 2013 May;123(5):1092-9 - PubMed
  14. N Engl J Med. 2013 Feb 28;368(9):876-8 - PubMed
  15. PLoS One. 2013 Oct 16;8(10):e76516 - PubMed
  16. Laryngoscope. 2014 Jul;124(7):1521-8 - PubMed
  17. PLoS One. 2014 Mar 17;9(3):e90777 - PubMed
  18. Acta Haematol. 2014;132(2):200-10 - PubMed
  19. Int Forum Allergy Rhinol. 2014 Nov;4(11):921-5 - PubMed
  20. Am J Respir Crit Care Med. 2014 Dec 1;190(11):1217-28 - PubMed
  21. Front Genet. 2015 Jan 26;6:1 - PubMed
  22. Laryngoscope. 2016 Apr;126(4):786-90 - PubMed
  23. Laryngoscope. 2016 May;126(5):1029-32 - PubMed
  24. PLoS One. 2016 Feb 11;11(2):e0147990 - PubMed
  25. Laryngoscope. 2016 Nov;126(11):2468-2474 - PubMed
  26. ERJ Open Res. 2016 Apr 29;2(2): - PubMed
  27. Lancet. 1979 Sep 1;2(8140):433-5 - PubMed

Publication Types